Radcliffe Capital Management, L.P. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 49 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$13,943
-50.0%
200,0490.0%0.00%0.0%
Q2 2023$27,877
+63.9%
200,0490.0%0.00%
+100.0%
Q1 2023$17,004
-99.2%
200,0490.0%0.00%
-98.5%
Q4 2022$2,052,503
+2.3%
200,0490.0%0.06%
+35.4%
Q3 2022$2,007,000
+0.2%
200,0490.0%0.05%
+4.3%
Q2 2022$2,003,000
+1.4%
200,0490.0%0.05%
+2.2%
Q1 2022$1,976,000200,0490.04%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Atalaya Capital Management LP 125,000$7,5000.01%
Q Global Advisors, LLC 195,489$110.01%
MMCAP International Inc. SPC 325,000$18,2000.01%
PERISCOPE CAPITAL INC. 867,072$48,5560.01%
MARSHALL WACE, LLP 78,611$2,543,0660.01%
HGC Investment Management Inc. 200,000$11,2000.00%
Spartan Fund Management Inc. 75,000$4,2000.00%
EHP Funds Inc. 125,186$7,0100.00%
COWEN AND COMPANY, LLC 522,096$29,2370.00%
Radcliffe Capital Management, L.P. 200,049$13,9430.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders